Best percentage change from baseline in tumor size of target lesions and best overall response in part 1 phase 1b.
PD, tumor
DISEASE, TUMOR, SOFT TISSUE SARCOMA, MALIGNANT PLEURAL MESOTHELIOMA
Selected tumor types in part 1 phase 1b evaluated included soft tissue sarcoma in arm 1, malignant pleural mesothelioma in arm 2, selected tumor types in basket arm 3 and arm 4. CR, complete response; PR, partial response; PD, progressive disease; Q3W, once every 3 weeks; Q6W, once every 6 weeks; SD, stable disease.